ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2018 American Transplant Congress

    Probability of Developing Chronic Kidney Disease 1 Year after Living Donor Nephrectomy Correlates with Baseline Kidney Volume and Function

    I. Hall, A. Shaaban, S. Beddhu, F. Shihab.

    University of Utah, Salt Lake City, UT.

    Purpose: Living kidney donor outcomes are tremendously important, especially given expanding donor eligibility. Relative to other predictors, the relationship between remaining kidney volume and post-donation…
  • 2018 American Transplant Congress

    Isolated Pre-Transplant Angiotensin II Type I Receptor Antibodies (AT1R Ab) Are Not Associated with Reduced Graft Function or Hypertension (HTN) in Pediatric Kidney Transplant (Ped KTx) Patients (pts)

    H. Pizzo, J. Choi, M. Haas, X. Zhang, E. Kamil, I. Kim, S. Jordan, D. Puliyanda.

    Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.

    Background: Pre-tx donor-specific antibodies (DSA) raises the risk for antibody-mediated rejection (ABMR) and graft dysfunction. The role of AT1R Ab is unclear. In adults, post-tx…
  • 2018 American Transplant Congress

    Analyzing Geographic Disparity in the US Heart Allocation System

    F. Karami,1 M. Nayebpour,2 M. Gentili,1 N. Koizumi,2 A. Rivard.3

    1Industrial Engineering, University of Louisville, Louisville, KY; 2Schar School of Policy and Government, George Mason University, Arlington; 3Department of Radiology, Cleveland Clinic, Abu Dhabi, United Arab Emirates.

    Introduction: In the United States, the system to allocate solid organs for transplantation is regulated and maintained by the United Network for Organ Sharing (UNOS).…
  • 2018 American Transplant Congress

    Survey of Rabbit Anti-Thymocyte Globulin Usage for Kidney Transplant Induction Therapy in the United States

    K. Foster,1 A. Dodson,2 K. Gutierrez.2

    1Samford University McWhorter School of Pharmacy, Birmingham, AL; 2Comprehensive Transplant Institute, UAB Hospital, Birmingham, AL.

    Background: Rabbit anti-thymocyte globulin (rATG) has become the most widely used induction agent in kidney transplantation (KTx) and has recently received FDA approval for this…
  • 2018 American Transplant Congress

    Autologous Adipose-Derived Stem Cells with In Vivo Immunomodulatory Properties Can Be Generated in Allograft Recipients under Immunosuppression

    A. Sicard,1 J. Rodriguez,2 P. Petruzzo,3 J. Kanitakis,4 O. Damour,2 L. Badet,5 A. Gazarian,6 F. Buron,1 O. Thaunat,1 K. Tarte,7 C. Mesnard,7 C. Auxenfans,2 E. Morelon.1

    1Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot Hospital, Lyon, France; 2Cells and Tissue Bank, Edouard Herriot Hospital, Lyon, France; 3University of Cagliari, Cagliari, Italy; 4Department of Dermatology, Edouard Herriot Hospital, Lyon, France; 5Department of Urology and Transplantation, Edouard Herriot Hospital, Lyon, France; 6Clinique du Parc, Lyon, France; 7University Hospital of Rennes, Rennes, France.

    PurposeTo determine if it is possible to generate mesenchymal stem cells (MSC) with potent in vivo immunomodulatory properties in allograft recipients under immunosuppression, we analyzed…
  • 2018 American Transplant Congress

    A Retrospective Review of De Novo Coccidioidomycosis among Remote Solid Organ Transplant Recipients in Arizona

    T. Zangeneh,1 J. August,1 N. Beatty,1 K. Asbury,2 L. Mi,2 J. Blair.2

    1Medicine/Division of Infectious Diseases, University of Arizona/Banner University Medical Center/Valley Fever Center for Excellence, Tucson, AZ; 2Medicine/Division of Infectious Diseases, Mayo Clinic Hospital, Phoenix, AZ.

    Background: Solid organ transplant (SOT) recipients residing in a Coccidioides-endemic region that acquire infection are at risk for complicated and protracted infection. Following transplantation, prophylaxis…
  • 2018 American Transplant Congress

    Characterization of Viral and Host Cell Genomic Alterations in EBV+ PTLD

    Y. Balachandran,1 M. McPherson,1 S. Boyd,2 C. Esquivel,1 S. Krams,1 O. Martinez.1

    1Abdominal Transplant, Stanford University, Stanford; 2Pathology, Stanford University, Stanford.

    Post-transplant lymphoproliferative disorder (PTLD) is a potentially fatal complication of organ transplantation characterized by abnormal proliferation of lymphoid cells in the setting of immunosuppression after…
  • 2018 American Transplant Congress

    Risk Factors and Outcomes with Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Bloodstream Infections among Solid Organ Transplant Recipients

    J. Anesi,1 E. Blumberg,1 E. Lautenbach,1 P. Tamma,2 K. Thom,3 K. Alby,1 W. Bilker,1 J. Omorogbe,1 P. Tolomeo,1 A. Werzen,3 K. Nemati,2 J. Han.1

    1University of Pennsylvania, Philadelphia, PA; 2Johns Hopkins University, Baltimore, MD; 3University of Maryland, Baltimore, MD.

    Objective: Solid organ transplant recipients (SOTR) have been significantly impacted by the emergence of multidrug-resistant bacteria, including extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae (EB). We determined the…
  • 2018 American Transplant Congress

    MERTK Mediates Transplant Tolerance via IFN-a Regulation of MDSCs and Tregs

    L. Zhang, M. DeBerge, E. Thorp, X. Luo.

    Northwestern University Feinberg School of Medicine, Chicago.

    Introduction: MERTK is one of the TAM receptor tyrosine kinases (RTKs) that mediate homeostatic phagocytosis of apoptotic cells, and transmit regulatory signals that modulate immune…
  • 2018 American Transplant Congress

    Pilot Study of Plasma Cell Niche-Targeted Therapy for Enhancement of Proteasome Inhibitor Effectiveness

    S. Tremblay,1 C. Castro-Rojas,2 J. Driscoll,1 S. Knechtle,3 A. Shields,1 R. Alloway,1 H. Singh,2 D. Hildeman,2 E. Woodle.1

    1UCincinnati, Cincinnati; 2Cincinnati Children's, Cincinnati; 3Duke, Durham.

    HLA antibody (Ab)-secreting bone marrow (BM) plasma cell (PC) survival depends on niche occupancy via a CXCR4 (PC)-CXCL12 (BM stromal cell) interaction. Plerixafor inhibits CXCR4-CXCL12…
  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 211
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences